Save time and get answers to complex questions with AI chat
Tenofovir generic patent?Does lipitor's use influence blood pressure medication type?Dabrafenib patent expiration?Somatuline depot patent expiry date?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for sivextro
Sivextro (tedizolid phosphate) treats acute bacterial skin and skin structure infections in adults. It is given orally as a 200 mg tablet once daily, with or without food, for 6 days. No dose adjustment is needed for mild to moderate liver or kidney impairment.[1]
Sivextro can also be administered intravenously as a 200 mg solution infused over 1 hour once daily. Switch to oral after 1-2 days if improvement occurs. Total treatment remains 6 days.[1]
For patients with severe renal impairment (CrCl <30 mL/min) or end-stage renal disease, no adjustment is required. Avoid in severe hepatic impairment (Child-Pugh C). No black box warnings apply to administration route.[1]
Take oral dose at the same time daily. IV requires compatible diluents like 0.9% sodium chloride or 5% dextrose. Do not mix with other drugs. Complete full course to prevent resistance.[1][2] [1] Sivextro Prescribing Information (Merck) [2] Drugs.com - Sivextro
Other Questions About Sivextro :